Back to results

Technische Universität Berlin

T-cell-directed bioorthogonal catalysis for localised prodrug activation in cancer therapy

Abstract

dc:description.abstract

Cancer is one of the most severe diseases worldwide, accounting for almost 10 million deaths a year. While modern cancer treatments have improved patient outcomes in many cancer types, solid cancers, metastases and relapse still pose immense challenges. Cancer treatments remain limited by poor efficacy due to tumour heterogeneity, immune evasion and acquired resistance or dose-limiting toxicities. Immunotherapy opened up new possibilities of targeted treatments to increase specificity, but strategies that enable selective activation of therapeutics at the tumour site remain scarce. As a result, there is a continued need for strategies that improve therapeutic efficacy, while minimising systemic toxicities. This thesis investigates the use of bioorthogonal catalysis in combination with engineered T-cells to locally activate anticancer drugs. Catalysis-augmented T-cell therapy is a newly developed platform technology, in which T-cells, engineered to express a surface protein upon cancer recognition, are used as an inducible antigen to recruit antibody-catalysts that facilitate drug activation in tumour proximity. To demonstrate this concept, we integrated a bioorthogonal catalyst with a single-domain antibody and demonstrated catalytic properties. A T-cell derived cell line was engineered and validated to inducibly express a surface antigen. Further recruitment of the antibody-catalyst to the activated T-cells was demonstrated. Functional studies showed that this system enabled catalytic activation of anticancer prodrugs in vitro, resulting in enhanced antitumour efficacy in target cells. These findings demonstrate a proof-of-concept to a potential strategy for a versatile platform therapy that could addressed key limitations of current therapies to increase efficacy with reduced off-target effects.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fiedler, Linus Andreas
Advisor dc:contributor.advisor
  • Rappsilber, Juri

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:depositonce.tu-berlin.de:11303/27307

Chain of custody

source
Harvested from
Technische Universität Berlin
Base URL
api-depositonce.tu-berlin.de/server/oai/request
Last updated
2026-07-27
Source record
OAI-PMH GetRecord
related terms
citation

Fiedler, Linus Andreas. T-cell-directed bioorthogonal catalysis for localised prodrug activation in cancer therapy. 2026. https://depositonce.tu-berlin.de/handle/11303/27307